Absolutely no way this drug comes back to life...in my opinion, and most sane people agree. This not like Tysabri or QCOR drug where there is a high need due to lack of comparable drugs or little competitive threat. The burden of proof is very high since the company took the drug off the market. Even if there were a chance, a company like Takeda does not have to be in a rush, while AFFY is in a hurry, before cash runs out or the banks come calling. Much better opps for a lottery pick out there!
Nope, not short. I do trade stocks, and just happened to notice this. I did buy only like 20 puts recently, but no big loss if my 'lottery' pick, like yours does not deliver. And I am not trying to help anyone per se, but if it was I, and I was betting on some huge upside....just maybe, you already got your big lottery on this for the year (?)